- September 30, 2021
Rabab Nasrallah is an investment professional with Earlybird Venture Capital based in Germany. As part of the Earlybird Health team, Rabab is focused on investing in companies across the healthcare space. Prior to this role, Rabab was the Program Manager for INCUBATE – an Australian accelerator supporting entrepreneurs with strong affiliation to the University of Sydney, Australia. With an extensive research background, Rabab has held roles in leading global research organisations in Australia and the UK, including The Babraham Institute, Cambridge. Rabab has a PhD in regenerative medicine from UNSW, Australia. As a postdoctoral fellow at the Babraham Institute, Rabab worked primarily in the field of immunology and therapeutic interventions.
